SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 202.50-2.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (20956)5/16/1998 11:39:00 PM
From: Machaon  Read Replies (8) of 32384
 
<< The company recently completed Phase III trials for Panretin Gel, a treatment for AIDS lesions, and plans to file a new drug application by the end of the quarter, while Targretin has shown early promise in breast-cancer therapies. >>

Nice coverage. We need more of this. Let's hope we get good news coverage out of the ASCO conference! We need the word Ligand to become more of a household word.

Regards, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext